| Standard dosage | 5 mg once daily; may increase to 10 mg once daily after 4-6 weeks; effective dosage range in clinical studies: 5-10 mg/day |
| Contraindications | No absolute contraindications |
| Main drug interactions | May increase serum concentration of succinylcholine, and caution is advised if these agents are used concurrently [35] |
| Main side effects | Insomnia and other sleep disorders (abnormal dreams, vivid dreams, nightmares), dose-related anorexia/weight loss, diarrhea, nausea, and/or vomiting; may cause bradycardia or heart block in some individuals, independent of their personal history of cardiac disease. Lower-weight patients (<55 kg) may experience more nausea, vomiting, and weight loss compared to higher-weight patients. |
| Special points | Considered to improve “cognitive symptoms” in Alzheimer's Disease, but not classified as a “disease-modifying” agent. |
| Cost-effectiveness | Expensive |